hidesy-shutterstock-com-1

hidesy / Shutterstock.com

1 October 2015EuropeAnja Lunze and Paul England

SPCs: When a few days makes a difference

On September 10, Advocate-General (AG) Niilo Jääskinen delivered his opinion in a case concerning supplementary protection certificates (SPCs). The case (C-471/14) was brought by Seattle Genetics against the Austrian Patent Office (APO).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

GSK triumphs in EPO appeal, revoking Pfizer patent

Herbert Smith Freehills and Kramer Levin in $2bn merger talks

CRISPR patents revoked following Nobel Prize winners’ withdrawal

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Teva faces $500m fine for antitrust breaches over MS drug

UK Budget: A missed opportunity?